Bio-gate AG Cash Flow-to-Debt Ratio
Bio-gate AG cash flow-to-debt ratio. Bio-gate AG (BIG1) has a Cash Flow-to-Debt Ratio of -0.56x as of December 2024, meaning its operating cash flow of €-1.22 Million could theoretically repay -1% of its total liabilities (€2.16 Million) in one year. See financial agility of Bio-gate AG to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bio-gate AG (2020–2024)
Cash flow-to-debt ratio of Bio-gate AG from 2020 to 2024. Historical debt coverage capacity for Bio-gate AG across 5 annual periods. Also explore Bio-gate AG annual equity growth to track the company's year-over-year net asset growth rate.
Bio-gate AG Cash Flow-to-Debt Ratio by Year (2020–2024)
Bio-gate AG cash flow-to-debt ratio by year from 2020 to 2024. Year-by-year debt coverage analysis for Bio-gate AG. For the full cash flow conversion analysis, see Bio-gate AG operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.56x | €-1.22 Million | €2.16 Million | ▼ -4.3% |
| 2023 | -0.54x | €-977.00K | €1.81 Million | ▲ +50.7% |
| 2022 | -1.10x | €-2.15 Million | €1.97 Million | ▼ -149.2% |
| 2021 | -0.44x | €-634.00K | €1.44 Million | ▼ -29.6% |
| 2020 | -0.34x | €-597.00K | €1.76 Million | — |